Purchases and Sales Made in Q3 2021 in Marker Therapeutics, Inc. (MRKR)
This table provides information about the institutional ownership of Marker Therapeutics, Inc. (MRKR) during Q3 2021. The information is specifically focused on institutions that hold shares of Marker Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-157K- 47.93% |
$264K - $452K
|
171K
$335K
|
|
|
Nov 15, 2021
Q3 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-175K- 27.75% |
$294K - $504K
|
456K
$894K
|
|
|
Nov 15, 2021
Q3 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-270K- 92.26% |
$454K - $779K
|
22.7K
$44.4K
|
|
|
Nov 15, 2021
Q3 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-476K- 35.16% |
$800K - $1.37M
|
878K
$1.72M
|
|
|
Nov 15, 2021
Q3 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-644K- 47.17% |
$1.08M - $1.85M
|
721K
$1.41M
|